KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

BACKGROUND AND AIMS: Increased expression of Chromosome Region Maintenance (CRM-1)/exportin-1 (XPO-1) has been correlated with poor prognosis in several aggressive tumors, making it an interesting therapeutic target. Selective Inhibitor of Nuclear Export (SINE) compounds bind to XPO-1 and block its...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Gravina, Giovanni Luca, Mancini, Andrea, Sanita, Patrizia, Vitale, Flora, Marampon, Francesco, Ventura, Luca, Landesman, Yosef, McCauley, Dilara, Kauffman, Michael, Shacham, Sharon, Festuccia, Claudio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4666032/
https://ncbi.nlm.nih.gov/pubmed/26620414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1936-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados